SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

Do Corticosteroids Really Raise Gestational Diabetes Risk?

Emerging research says the steroids aren’t a major driver of gestational diabetes, but impacts vary depending on the patient.

From Taboo to Test: Can Menstrual Blood Aid Diagnosis?

Emerging research suggests that menstrual blood may provide valuable diagnostic and biological insights, with potential applications in cancer screening and endometriosis detection.

No Increased Retinopathy Risk Seen With Tirzepatide

No changes in diabetic retinopathy status occurred in high-risk people with type 2 diabetes taking tirzepatide when compared with dulaglutide.

Petrelintide Tolerability Could Improve on GLP-1 Challenges

The amylin analog petrelintide reduces body weight with 'placebo-like' tolerability, a phase 2 trial shows.

CGM Monitoring Benefits Extend to Non-Insulin-Using T2D

Patients with type 2 diabetes not taking insulin who use continuous glucose monitoring show significant reductions in A1c.

Obesity Meds Improve Patients' Perceived Physical Function

Obesity management medications improve patients' perceived physical function and have a 'modest' impact on an objective functional measure.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Latest News

Emerging research says the steroids aren’t a major driver of gestational diabetes, but impacts vary depending on the patient.

Emerging research suggests that menstrual blood may provide valuable diagnostic and biological insights, with potential applications in cancer screening and endometriosis detection.

No changes in diabetic retinopathy status occurred in high-risk people with type 2 diabetes taking tirzepatide when compared with dulaglutide.

The amylin analog petrelintide reduces body weight with 'placebo-like' tolerability, a phase 2 trial shows.

Patients with type 2 diabetes not taking insulin who use continuous glucose monitoring show significant reductions in A1c.

Obesity management medications improve patients' perceived physical function and have a 'modest' impact on an objective functional measure.

News All Time

Gestational GLP-1s Tied to Adverse Obstetric Outcomes

Underlying diabetes and discontinuation rebound in mothers with overweight are likely responsible rather than the drug itself.

Eating Out Exacerbating the Global Obesity Epidemic

Eating out instead of preparing food at home is exacerbating the global obesity epidemic, with half of adults worldwide eating out at least once a week.

Fezolinetant Linked to Enzyme Elevations

Fezolinetant is associated with a hepatic adverse event reporting signal characterized primarily by transaminase elevations rather than clinically overt liver injury.

GLP-1 Apps: Helpful Companions or False Sense of Security?

GLP-1 consumer apps can help patients stay on track but have no evidence base; clinical-grade apps can do more but are not accessible to most patients.

Study Sheds Light on Burden of Rare Bone Disease in France

Fibrous dysplasia or McCune-Albright syndrome affects approximately 5 per 1,000,000 hospitalised patients in France, with higher rates observed among children and women.

Surgery or Meds for Weight Regain After Sleeve Gastrectomy?

A retrospective study finds that conversion surgery after sleeve gastrectomy produces greater long-term weight loss than obesity medications for recurrent weight gain.

Modest Protein Restriction Tied to Better Outcomes in CKD

A moderately protein-restricted diet is tied to favorable kidney outcomes in patients with chronic kidney disease stage III or IV, according to a recent retrospective study.

Inhaled Insulin Okayed for Kids With Diabetes Aged 6+ Years

The FDA first approved MannKind’s Afrezza for adults with diabetes in 2014.

The Latest in GLP-1-Based Therapy to be Featured at ADA

New receptor agonist combinations, a once-monthly GLP-1, and full retatrutide data are all on the agenda, along with a huge spectrum of other diabetes-related content.

Processed Meat May Raise Gastric and Oesophageal Cancer Risk

The consumption of processed meat is associated with an increased risk for gastric cancer and oesophageal adenocarcinoma, a multicentre cohort study reports.

Continuous Glucose Monitoring: Is It Time to Expand Use?

Growing evidence suggests that continuous glucose monitoring improves glycemic control, treatment decisions, and patient engagement in people with type 2 diabetes.

Time-Restricted Eating Reshapes Gut Flora, Aids Weight Loss

Time-restricted eating alters the gut microbiota and serum metabolite profiles in young adults with overweight or obesity, with changes linked to weight loss and improved cardiometabolic health.

Tirzepatide Raises Thyroid Risk in Certain At-Risk Patients

Patients with end-stage renal disease or preexisting thyroid disease are more likely to experience either a new thyroid problem or a worsening of their thyroid disease while on tirzepatide.

Is It Time to Talk to Patients About Bowel Hygiene?

Advising patients about bowel hygiene is on the rise as understanding grows about the multifaceted nature of GI disorders.

France Becomes First EU Country to Reimburse Anti-obesity Drugs, Minister Says

France will reimburse the cost of weight-loss drugs prescribed to severely obese patients from mid-June in a ⁠first for a European Union country, Health Minister Stephanie...

PFAS Linked to Lower Bone Density in Youth

Data from the long-running HOME study links higher exposure to certain polyfluoroalkyl substances ‘forever chemicals’ with lower bone mineral density in children and adolescents.

Recommended News For You

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer

Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.

Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

Recommended Articles For You

Understanding Lymphedema: Symptoms, Causes, and Treatment  

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025 

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late 

Cardio-Oncology: Managing Heart Failure in Survivors of Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.

2.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

3.

The pathology of incurable cancers can be predicted thanks to research.

4.

Breast cancer surgery: Study finds overnight hospital stay not important for older patients

5.

Measurable Residual Disease Predicts Real-World AML Relapse

1.

The Benefits and Side Effects of Vidaza Syndrome 

2.

The Unseen Danger of Anal Cancer: How to Protect Yourself

3.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

4.

Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment

5.

Unlocking the Potential of Palbociclib: A Comprehensive Overview

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Lung Cancer Congress®

5.

Genito-Urinary Oncology Summit 2026

1.

Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.

2.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

5.

Navigating the Complexities of Ph Negative ALL - Part XIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot